Seeing Is Believing
Currently out of the existing stock ratings of Amy Li, 4 are a BUY (100%).
Analyst Amy Li, currently employed at JEFFERIES, carries an average stock price target met ratio of 75% that have a potential upside of 28.92% achieved within 75 days.
Amy Li’s has documented 8 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LQDA, Liquidia Technologies at 13-Jan-2026.
Analyst best performing recommendations are on LQDA (LIQUIDIA TECHNOLOGIES).
The best stock recommendation documented was for IRWD (IRONWOOD PHARMACEUTICALS) at 4/15/2025. The price target of $0.7 was fulfilled within 6 days with a profit of $0.02 (2.78%) receiving and performance score of 4.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Jun-2018
$30
$21.24 (242.47%)
$75
3 months 27 days ago
(11-Mar-2026)
3/17 (17.65%)
$19.54 (186.81%)
1348
Hold Since 26-Dec-2025
$10
$1.24 (14.16%)
$11
4 months 4 days ago
(04-Mar-2026)
4/18 (22.22%)
$-0.61 (-5.75%)
23
Buy Since 24-Jul-2024
$21
$12.24 (139.73%)
6 months 2 days ago
(06-Jan-2026)
0/6 (0%)
$11.38 (118.30%)
Buy Since 06-Feb-2024
$11
$2.24 (25.57%)
$26
7 months 12 days ago
(26-Nov-2025)
2/6 (33.33%)
$1.52 (16.03%)
26
Buy Since 04-Jan-2023
$15
$6.24 (71.23%)
$55
7 months 18 days ago
(20-Nov-2025)
6/12 (50%)
$5.37 (55.76%)
63
Which stock is Amy Li is most bullish on?
What Year was the first public recommendation made by Amy Li?